ANIP News and Press, ANI Pharmaceuticals Inc. From 04/13/20

The FDA has accepted for review an application from ANI Pharmaceuticals ( ANIP -2.9% ) seeking approval to re-commercialize Purified Cortrophin Gel (repository corticotropin injection USP) 80U/mL. The agency's action date is July 23. More news on: ANI Pharmaceuticals, Inc., Mallinckrod...

BAUDETTE, Minn. , April 13, 2020 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that the U.S. Food & Drug Administration ("FDA") has accepted its supplemental new drug application ("sNDA") for Purified Cortrophin® Gel (Repository Cortic...

ANI Pharmaceuticals ( ANIP +1.6% PM) launched their 49th commercial generic drug - Omega-3-Acid Ethyl Esters Capsules, 1 gram. More news on: ANI Pharmaceuticals, Inc., Healthcare stocks news, Read more ...

BAUDETTE, Minn. , April 2, 2020 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the launch of Omega-3-Acid Ethyl Esters Capsules USP, 1 gram.  The current annual U.S. market for this product is approximately $110 million , according to IQVIA/IMS...

BAUDETTE, Minn. , March 26, 2020 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the launch of Polyethylene Glycol 3350, 17g/Packet (PEG-3350). The current annual market for this over the counter (OTC) product is approximately $21 million , according...

ANI Pharmaceuticals ( ANIP +13.1% ) has filed a marketing application with the FDA seeking approval to reintroduce Purified Cortrophin Gel (repository corticotropin injection USP) (80 U/mL) into the U.S. market aimed at taking market share from Mallinckrodt's ( MNK +0.6% ) top seller A...

BAUDETTE, Minn. , March 24, 2020 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP), an emerging leader in the specialty pharmaceutical industry, today announced that it has submitted a prior approval supplement (PAS) to the Endocrinology Division at the FDA for re-comm...

Image source: The Motley Fool. ANI Pharmaceuticals Inc   (NASDAQ: ANIP) Q4 2019 Earnings Call Feb 27, 2020 , 10:30 a.m. ET Operator Continue reading

ANI Pharmaceuticals, Inc. (ANIP) Q4 2019 Earnings Conference Call February 27, 2020, 10:30 AM ET Company Participants Arthur Przybyl - CEO Stephen Carey - CFO Conference Call Participants Dana Flanders - Guggenheim Elliot Wilbur - Raymond James Brandon Folkes - Cantor Fit...

ANI Pharmaceuticals (NASDAQ: ANIP ): Q4 Non-GAAP EPS of $1.08 misses by $0.10 ; GAAP EPS of -$0.41 misses by $0.56 . More news on: ANI Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...